Share this article
MINNEAPOLIS, Jan. 26, 2021 /PRNewswire/
Vireo Health International Inc., ( Vireo or the Company ) (CNSX: VREO,OTCQX: VREOF), the leading physician-founded, science-focused multi-state cannabis company, announced today that its Form 10 Registration Statement filed with the U.S. Securities and Exchange Commission (the SEC ) became effective earlier this month.
The Company will now be subject to U.S. GAAP reporting requirements of the SEC, as well as the requirements of the Securities Act of 1933, as amended, and the Exchange Act of 1934, as amended. The Company will now begin filing annual reports with the SEC on Form 10-K, quarterly reports on Form 10-Q, periodic reports on Form 8-K, and have additional reporting obligations related to proxy materials and insider security ownership and transactions.
Solvay-Chefin: „Die Mutter aller Industrien muss sich neu erfinden handelsblatt.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from handelsblatt.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
MINNEAPOLIS, Jan. 8, 2021 /PRNewswire/ Vireo Health International Inc., ( Vireo or the Company ) (CNSX: VREO,OTCQX: VREOF), the leading physician-founded, science-focused multi-state cannabis company, today announced that the Company has launched a new line of naturally-augmented cannabis flower called Amplifi™. The product line will feature dry cannabis flower strains sold in 3.5-gram TerpSafe
TM jars. Amplifi is the first brand that utilizes Vireo s new TerpSafe packaging technology, a proprietary patent-pending system that not only preserves the existing terpene profile but can naturally augment the terpene content of cannabis flower over time.
Vireo s new terpene enhanced dry flower cannabis line, Amplifi TM, packaged in the Company s TerpSafe TM packaging.